Literature DB >> 11845853

Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation.

Ara A Vaporciyan1, Kelly W Merriman, Ferrah Ece, Jack A Roth, W Roy Smythe, Stephen G Swisher, Garrett L Walsh, Jonathan C Nesbitt, Joseph B Putnam.   

Abstract

BACKGROUND: The prevention of major pulmonary events (MPEs) after pneumonectomy may minimize postoperative mortality rates. The purpose of this study was to identify preoperative and perioperative factors associated with the development of MPEs after pneumonectomy to help predict which patients are at increased risk for MPEs.
METHODS: We retrospectively reviewed the medical records of all patients (n = 261) who underwent pneumonectomies between January 1990 and May 1999. We analyzed preoperative and perioperative risk factors, the primary end point of an MPE and the secondary end points of mortality (in-hospital or 30 days postprocedure), length of stay, and hospital charges. A postoperative MPE included only pneumonia or acute respiratory distress syndrome as defined by the Centers for Disease Control and the American and European Consensus Conference's established criteria. Simple atelectasis that did not progress to pneumonia or a documented aspiration was not included.
RESULTS: Four patients died within 12 hours of operation; the records of the remaining 257 patients were analyzed. An MPE occurred in 33 (12.8%) of 257 patients; 16 (6.2%) of 257 patients died. A multivariate analysis performed on relevant variables showed that only the timing of smoking cessation (1 month or sooner before operation) was a significant predictor of an MPE. Age, side of pneumonectomy, and the use of preoperative chemotherapy or combined chemotherapy and radiation therapy were not significant predictors of an MPE. An MPE significantly increased the mortality rate 2.1% versus 39.3%, p < 0.001).
CONCLUSIONS: Mortality after pneumonectomy increased significantly with the development of an MPE. Patients who continue to smoke within 1 month of operation are at an increased risk for developing an MPE. Interventions to minimize MPEs may minimize the mortality rate after pneumonectomy.

Entities:  

Mesh:

Year:  2002        PMID: 11845853     DOI: 10.1016/s0003-4975(01)03443-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  33 in total

Review 1.  Smoking cessation and lung cancer: oncology nurses can make a difference.

Authors:  Mary E Cooley; Rebecca L Sipples; Meagan Murphy; Linda Sarna
Journal:  Semin Oncol Nurs       Date:  2008-02       Impact factor: 2.315

Review 2.  Surgical treatment of non-small-cell lung cancer in octogenarians.

Authors:  Miguel Guerra; Paulo Neves; José Miranda
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-08

3.  Dual cigarette and e-cigarette use in cancer survivors: an analysis using Population Assessment of Tobacco Health (PATH) data.

Authors:  Yael R Symes; Kurt M Ribisl; Marcella H Boynton; J Lee Westmaas; Deborah K Mayer; Shelley D Golden
Journal:  J Cancer Surviv       Date:  2019-01-24       Impact factor: 4.442

Review 4.  Optimizing health before elective thoracic surgery: systematic review of modifiable risk factors and opportunities for health services research.

Authors:  Sean M Stokes; Elliot Wakeam; Mara B Antonoff; Leah M Backhus; Robert A Meguid; David Odell; Thomas K Varghese
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

5.  Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research.

Authors:  Stephanie R Land; Graham W Warren; Jennifer L Crafts; Dorothy K Hatsukami; Jamie S Ostroff; Gordon B Willis; Veronica Y Chollette; Sandra A Mitchell; Jasmine N M Folz; James L Gulley; Eva Szabo; Thomas H Brandon; Sonia A Duffy; Benjamin A Toll
Journal:  Cancer       Date:  2016-03-28       Impact factor: 6.860

6.  Disparities between blacks and whites in tobacco and lung cancer treatment.

Authors:  Elyse R Park; Sandra J Japuntich; Lara Traeger; Sheila Cannon; Hannah Pajolek
Journal:  Oncologist       Date:  2011-09-29

Review 7.  Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward.

Authors:  Namrata Vijayvergia; Prashant C Shah; Crystal S Denlinger
Journal:  J Natl Compr Canc Netw       Date:  2015-09       Impact factor: 11.908

8.  Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials.

Authors:  Erica N Peters; Essie Torres; Benjamin A Toll; K Michael Cummings; Ellen R Gritz; Andrew Hyland; Roy S Herbst; James R Marshall; Graham W Warren
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

9.  Predictors of atelectasis after pulmonary lobectomy.

Authors:  Alan J Stolz; Jan Schutzner; Robert Lischke; Jan Simonek; Tomas Harustiak; Pavel Pafko
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

10.  Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.

Authors:  Alexis J Platek; Vijayvel Jayaprakash; Mihai Merzianu; Mary E Platek; David M Cohan; Wesley L Hicks; Sathiya P Marimuthu; Timothy B Winslow; Vishal Gupta; Hassan Arshad; Moni A Kuriakose; Shiva Dibaj; James R Marshall; Mary E Reid; Graham W Warren; Anurag K Singh
Journal:  Laryngoscope       Date:  2016-06-27       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.